Patent directory · USPTO A61K / A61P
Patents matching “TAKEDA GMBH”
41 pharma patents match "TAKEDA GMBH" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 41 pharmaceutical patents matching "TAKEDA GMBH" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11690839
Treatment of idiopathic pulmonary fibrosis
granted -
US 11179384
Treatment of nonalcoholic fatty liver disease
granted -
US 11173208
Liquid formulation comprising GM-CSF neutralizing compound
granted -
US 10758621
Liquid formulation comprising GM-CSF neutralizing compound
granted -
US 10745475
Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
granted -
US 9962377
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted -
US 9919051
Liquid formulation comprising GM-CSF neutralizing compound
granted -
US 9833410
Lyophilized formulation comprising GM-CSF neutralizing compound
granted -
US 9422327
Process for preparing crystalline ciclesonide with defined particle size
granted -
US 9387205
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted -
US 9376442
Methylpyrrolopyrimidinecarboxamides
granted -
US 9340522
Pyrazolone-derivatives and their use as PDE-4 inhibitors
granted -
US 9309187
EP2 receptor agonists
granted -
US 9205044
Aqueous pharmaceutical preparation comprising roflumilast
granted -
US 9149479
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted -
US 9090597
Pyrazolone derivatives as PDE4 inhibitors
granted -
US 9018175
3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives
granted -
US 8927557
Methylpyrrolopyrimidinecarboxamides
granted -
US 8883818
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted -
US 8865745
Pyrazolone derivatives as PDE4 inhibitors
granted -
US 8829189
Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
granted -
US 8816085
Methylpyrrolopyridinecarboxamides
granted -
US 8758817
Dosage form containing (S)-pantoprazole as active ingredient
granted -
US 8754218
Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
granted